7Baggers
 Why AstraZeneca Crashed 6%, Leading Two Rivals, Including Pfizer, To Jump  Investor's Business Daily Thu, 09 Jul 2026 20:26:00 GMT
 Alnylam jumps as rival ATTR-CM setback appears to strengthen Amvuttra outlook  Quiver Quantitative Thu, 09 Jul 2026 14:50:00 GMT
 Why is Alnylam Pharmaceuticals stock surging today?  Investing.com Thu, 09 Jul 2026 14:17:54 GMT
 ALNY Stock Rallies As RNAi Expansion And AI Deals Deepen  StocksToTrade Thu, 09 Jul 2026 14:04:00 GMT
 AstraZeneca's Stock Drops on Wainua's Setback in ATTR-CM Study  Yahoo Finance Thu, 09 Jul 2026 13:54:00 GMT
 BridgeBio Pharma (BBIO) and Alnylam Pharma (ALNY) Surge After As  GuruFocus Thu, 09 Jul 2026 12:27:45 GMT
 AstraZeneca, Ionis drug fails big heart disease study in major setback  BioPharma Dive Thu, 09 Jul 2026 12:17:37 GMT
 Alnylam, BridgeBio shares surge as rival’s heart drug fails late-stage trial  Investing.com Nigeria Thu, 09 Jul 2026 10:07:26 GMT
 Aliramb Pharmaceutical competitor Wainua suffers key trial failure  富途牛牛 Thu, 09 Jul 2026 09:52:54 GMT
 Can Alnylam's Drug Pipeline Fuel Its Long-Term Revenue Growth?  Yahoo Finance Singapore Mon, 06 Jul 2026 15:55:00 GMT
 ALNY - Alnylam Pharmaceuticals Inc Volatility & Greeks  Finviz Sun, 05 Jul 2026 23:07:29 GMT
 alny - alnylam pharmaceuticals inc latest sec filings  Finviz Sun, 05 Jul 2026 18:28:19 GMT
 alny - alnylam pharmaceuticals inc volatility & greeks  Finviz Sat, 04 Jul 2026 06:38:00 GMT
 alnylam stock leans on rna medicines. investors watch the u.s. listing.  Ad-hoc-news.de Fri, 03 Jul 2026 14:23:46 GMT
 what offers alnylam pharmaceuticals (alny) sustained long-term growth?  Insider Monkey Fri, 03 Jul 2026 12:02:05 GMT
 canaccord reiterates alnylam stock buy rating after rnai event  Investing.com Tue, 30 Jun 2026 07:00:00 GMT
 alny maintains buy rating -- price target lowered by hc wainwrig  GuruFocus Mon, 29 Jun 2026 10:51:28 GMT
 Number of shareholders of Alnylam Pharmaceuticals, Inc – BX:DUL  TradingView Sat, 27 Jun 2026 10:58:14 GMT
 alny forecast — price target — prediction for 2027  TradingView Thu, 25 Jun 2026 18:57:21 GMT
 alnylam expands ai partnership with komodo health  Investing.com Thu, 25 Jun 2026 13:48:26 GMT
 alnylam pharmaceuticals inc rnai roundtable webcast transcript  GuruFocus Thu, 25 Jun 2026 07:00:00 GMT
 regeneron gets us, eu review for myasthenia gravis drug (regn)  Seeking Alpha Tue, 23 Jun 2026 18:34:20 GMT
 dyne therapeutics adds ex-sage ceo barry greene to board  Stock Titan Mon, 22 Jun 2026 20:10:00 GMT
 Alnylam scolded over promotional activity after Pfizer complaint  Fierce Pharma Mon, 22 Jun 2026 07:00:00 GMT
 Can Alnylam's Broader Portfolio Ease Its Dependence on Amvuttra?  Yahoo Finance Mon, 22 Jun 2026 07:00:00 GMT
 alny - alnylam pharmaceuticals inc volatility & greeks  Finviz Sun, 21 Jun 2026 13:56:26 GMT
 alnylam pharmaceuticals inc  TradingKey Wed, 17 Jun 2026 05:19:58 GMT
 alnylam expands genesis pharma collaboration in europe  MSN Sun, 14 Jun 2026 23:32:30 GMT
 Alnylam Taps Generative AI And Nordic Expansion As Market Lags Targets  Yahoo Finance Sun, 14 Jun 2026 07:00:00 GMT
 understanding momentum shifts in (alny)  Stock Traders Daily Sat, 13 Jun 2026 16:56:02 GMT
 alnylam pharmaceuticals stock hits 52-week low at $282.71 by investing.com  Investing.com Nigeria Sat, 13 Jun 2026 09:50:28 GMT
 Can Alnylam Rely on Amvuttra to Sustain Its Rapid Sales Momentum?  Yahoo Finance Fri, 12 Jun 2026 07:00:00 GMT
 alnylam pharmaceuticals stock hits 52-week low at $282.71  Investing.com Fri, 12 Jun 2026 07:00:00 GMT
 alnylam to host tenth “rnai roundtable” webcast series  Business Wire Fri, 12 Jun 2026 07:00:00 GMT
 what does the alnylam-inceptive ai deal entail  Kavout Thu, 11 Jun 2026 16:59:39 GMT
 alnylam expands genesis pharma deal in europe (alny:nasdaq)  Seeking Alpha Wed, 10 Jun 2026 07:00:00 GMT
 genesis pharma expands alnylam partnership to nordic markets  Investing.com Wed, 10 Jun 2026 07:00:00 GMT
 alnylam expands genesis pharma collaboration in europe  Seeking Alpha Wed, 10 Jun 2026 07:00:00 GMT
 city banks nearly $100m for next-gen rnai drugs  BioPharma Dive Mon, 08 Jun 2026 20:28:13 GMT
 city therapeutics gets $99m to gather data on three rnai medicines  Endpoints News Mon, 08 Jun 2026 18:30:19 GMT
 the week in pharma: action, reaction and insight – week to june 5, 2026  The Pharma Letter Sun, 07 Jun 2026 10:09:09 GMT
 h.c. wainwright reiterates alnylam stock buy rating at $510  Investing.com Fri, 05 Jun 2026 13:12:12 GMT
 alnylam in billion-dollar deal with inceptive  Biostock Thu, 04 Jun 2026 12:26:05 GMT
 alnylam signs $2 billion ai pact with inceptive  The Pharma Letter Thu, 04 Jun 2026 09:07:58 GMT
 Alnylam, Inceptive ink AI deal potentially worth $2B  BioPharma Dive Thu, 04 Jun 2026 07:00:00 GMT
 Alnylam hops on AI train with up to $2B Inceptive partnership  BioSpace Thu, 04 Jun 2026 07:00:00 GMT
 Alnylam Enters $2 Billion Strategic AI Collaboration with Inceptive  Pharmaceutical Executive Thu, 04 Jun 2026 07:00:00 GMT
 Alnylam Bets on AI for Speedy RNAi Drug Discovery and Development  Yahoo Finance Thu, 04 Jun 2026 07:00:00 GMT
 AI Collaboration Puts Alnylam’s RNAi Pipeline Productivity In Focus  simplywall.st Thu, 04 Jun 2026 07:00:00 GMT

Alnylam Pharmaceuticals, Inc
(NASDAQ:ALNY) 

ALNY stock logo

Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing RNA interference (RNAi) therapeutics. The company's pipeline of investigational RNAi therapeutics focus on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, an...

Founded: 2002
Full Time Employees: 1,323
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends